secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vera Therapeutics, Inc. (VERA)
CIK:        0001831828
Form:       8-K
Filed at:   2025-12-18T23:59:59+00:00
Accession:  0001193125-25-323298
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud

Vera Therapeutics Announces Departure of Chief Legal Officer Jason Carter
-------------------------------------------------------------------------

- Jason Carter will cease to be Chief Legal Officer of Vera Therapeutics, effective December 24, 2025.
- The departure was announced on December 16, 2025, and filed on Form 8-K.
- No reason for the departure was disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831828/000119312525323298/0001193125-25-323298-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831828/000119312525323298/d26538d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-323298

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer